CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Erdtmann Rainer M See Remarks | Gift | −10,000 | 653,027 | ||
| 2025-01-31 | Erdtmann Rainer M See Remarks | Gift | +10,000 | 20,000 | ||
| 2025-01-31 | Erdtmann Rainer M See Remarks | Gift | −10,000 | 643,027 | ||
| 2025-01-31 | Erdtmann Rainer M See Remarks | Gift | +10,000 | 20,000 | ||
| 2025-01-28 | Erdtmann Rainer M See Remarks | Gift | −40,000 | 673,027 | ||
| 2024-11-30 | Valle Franco Chief Financial Officer | Grant or award | +495 | $6.15 | $3K | 42,995 |
| 2024-09-30 | Hitchcock Michael J.M. Director | Purchase | +10,000 | $10.06 | $101K | 15,000 |
| 2024-06-12 | Ray Sumita Director | Grant or award · Stock Option (Right to Buy) | +51,025 | 51,025 | ||
| 2024-06-12 | Faust Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +51,025 | 51,025 | ||
| 2024-06-12 | Hitchcock Michael J.M. Director | Grant or award · Stock Option (Right to Buy) | +51,025 | 51,025 | ||
| 2024-06-12 | AGUIAR ERIC Director | Grant or award · Stock Option (Right to Buy) | +51,025 | 51,025 | ||
| 2024-06-12 | Chen Bihua Director | Grant or award · Stock Option (right to buy) | +51,025 | 51.03 | ||
| 2024-06-11 | Valle Franco Chief Financial Officer | Purchase | +12,509 | $4.43 | $55K | 42,500 |
| 2024-05-31 | Valle Franco Chief Financial Officer | Grant or award | +4,448 | $3.78 | $17K | 29,991 |
| 2024-05-31 | Frias Juan Pablo Chief Medical Officer | Grant or award | +349 | $8.94 | $3K | 349 |
| 2024-01-17 | Butler Thomas Andrew Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +407,502 | 407,502 | ||
| 2024-01-17 | Valle Franco Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +145,245 | 145,245 | ||
| 2024-01-17 | Erdtmann Rainer M President and COO | Grant or award · Stock Option (Right to Buy) | +135,700 | 135,700 | ||
| 2024-01-17 | Frias Juan Pablo Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +111,090 | 111,090 | ||
| 2023-12-29 | Erdtmann Rainer M President and COO | Gift | −3,000 | 731,027 |
Page 2 of 6 · 106 trades